-
公开(公告)号：EP3381922A1
公开(公告)日：2018-10-03
申请号：EP16868013.0
申请日：2016-11-24
发明人： PENG, Yan , LIU, Fei , CHEN, Zhilin , ZHANG, Yayu , HU, Zhongyuan , JIANG, Jinfeng
IPC分类号： C07D519/00 , A61K31/522 , A61P3/10
摘要： The present invention belongs to the field of drug crystals, relates to crystals of thiadiazole derivative DPP-IV inhibitors, and in particular relates to A and B type crystals of the compound as shown in formula 7. The crystals of the present invention have excellent stability. For example, under high temperature, high humidity or light test conditions, the material contents associated with the crystal of the compound of formula 7 do not change significantly. In addition, the crystal of the present invention also has a very good powder flowability and satisfies the requirements of drug preparation and production.
-
公开(公告)号：EP3381922B1
公开(公告)日：2020-10-21
申请号：EP16868013.0
申请日：2016-11-24
发明人： PENG, Yan , LIU, Fei , CHEN, Zhilin , ZHANG, Yayu , HU, Zhongyuan , JIANG, Jinfeng
IPC分类号： C07D519/00 , A61K31/522 , A61P3/10
-
公开(公告)号：EP3896063A1
公开(公告)日：2021-10-20
申请号：EP19897084.0
申请日：2019-12-13
发明人： QIAN, Wenyuan , WANG, Hongjian , ZHANG, Ming , LIU, Fei , XING, Lei , HU, Zhongyuan , GUO, Yahui , LIU, Yanlong , ZHANG, Huihui
IPC分类号： C07D401/14 , A61K31/498 , A61K31/4709 , A61P35/00 , A61P29/00
摘要： Provided is a salt of an Syk inhibitor and a crystalline form thereof, and more specifically, provided are 5-fluoro-1-methyl-3-((5-(4-(oxetan-3-yl)piperazine-1)-yl)pyridin-2-yl)amino)-6-(1H-pyrazol-3-yl)quinoline-2(1H )-ketamine hydrochloride, a crystalline form thereof, a preparation method therefor, a pharmaceutical composition thereof and a use thereof. The hydrochloride of the compound represented by formula I and the crystalline form thereof have good salt-forming properties, high stability and low hygroscopicity, have advantages in terms of physical properties, safety and metabolic stability, and have value in prepared medicines.
-
-
搜索结果
3 条记录 (耗时 0.012 秒)
